Albert Bourla, Pfizer CEO (Laurent Gillieron/Keystone via AP Images)
Pfizer's RSV vaccine for older adults nabs FDA adcomm recommendation
FDA’s vaccine advisory committee gave a thumbs-up to Pfizer’s RSV vaccine on Tuesday, setting the stage for GSK’s RSV adcomm coming on Wednesday.
After more …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
